Prognostic accuracy in second-line renal cancer therapy

Lancet Oncol. 2015 Mar;16(3):240-1. doi: 10.1016/S1470-2045(15)70009-4. Epub 2015 Feb 12.

Author

Axel Bex¹

Affiliation

¹ Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: [email protected].

PMID: 25681968
DOI: 10.1016/S1470-2045(15)70009-4

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Renal Cell / drug therapy*
Decision Support Techniques*
Female
Humans
Kidney Neoplasms / drug therapy*
Male
Molecular Targeted Therapy*
Salvage Therapy*